Archives: Speakers

Kento Nakamura is a global professional having worked both in the Western and Eastern healthcare landscapes. He has been in various roles, contributing significantly to drug development, market access, and pharmaceutical marketing.

At CMIC, Japan and South Korea’s first CRO, Kento wears multiple hats including helping formulate corporate strategy, creating mutually beneficial partnerships with other companies, and taking initiative to create business development opportunities.

During his tenure at KM Pharmaceutical Consulting, a boutique drug development consulting firm, Kento co-pioneered the market access perspective on drug development, resulting in key additional endpoints in an ongoing phase 2 study. He also played a crucial role in developing the global drug safety plan, ensuring compliance with reporting requirements across multiple continents.

Kento holds an MPH in Health Management from Harvard University and a BS in Biology from Tufts University. He is fluent in English and Japanese. In his free time, Kento enjoys playing tennis, watching football, visiting contemporary art museums, and traveling around the world.

International Operations and Business Development Executive with a proven track record for establishing and growing specialty Clinical Research Organizations. Biometrics Expert with over 30 years of industry experience guiding drug, biologic, and medical device products successfully through the development process. Extensive international operations and business development experience. Passionate about helping organizations and teams achieve their full potential.

Physician-scientist executive with experience in the industry (pharma, biotech & CRO). Leadership role with focus on patient centric innovation, building and leading high performing teams in Early to Late Phase Product development, launch and life-cycle management, business development, due diligence and integration. Ability to integrate development and operations experience in various TA’s including Immunology, Oncology, Neurology and Transplantation.
All opinions and views are my own.

I’m a clinical finance and operations leader with 20+ years of experience driving global strategies for clinical trial financial planning, strategic outsourcing, vendor management, site contracts and budgets, and investigator grant payments.

I specialize in optimizing systems and workflows to ensure accuracy, compliance, and audit readiness, while building strong cross-functional partnerships across Clinical Operations, Finance, Legal, and Outsourcing.

My experience is predominantly with early-stage biotech, preparing for Phase 1 trials and IPO in 1-3 years. While hands on, as the portfolio grows, I’ve built and led Clinical Business Operations teams.

I enjoy solving complex problems, mentoring teams, implementing automation tools, and working at the intersection of data, people, and purpose-ultimately enabling faster, more transparent trials that serve patients and sites alike, while ensuring financial control and compliance with regulatory requirements.

Richard Graham, founder of Mirador Therapeutics and TruTechnologies, is a seasoned leader with extensive experience in business operations, corporate strategy, fundraising, scientific research, and therapeutics development. He excels at aligning corporate strategy with scientific expertise and building partnerships with executives, board members, and investors.

A proven leader in global team management, Rick has successfully driven large-scale R&D programs from concept to completion, consistently achieving ambitious milestones. His work has advanced therapeutics through late-stage development, contributing to the approvals of Erivedge™, Kadcyla™, Kyprolis™, Perjeta™, and Yupelri™.

Clinical Research, Bio-Tech, expert with over 18 years of experience working in the Life Sciences Industry. Brings a unique blend of clinical trial expertise, safety management, scientific and technology consulting. Possesses strong team-working, leadership, communication skills and attention to detail. Enthusiastic and excited about furthering the cause of clinical research.

I was born in Australia and reside in New York City, NY and I am fortunate to be in an extremely active family. Being from this environment with active siblings had thrust me into a leadership position early in my life and I have embraced that leadership mentality ever since. I wake every morning thankful for the great family and friends I now call family.